Looking at a slightly longer term, the performance of PFE stock with respect to the index has been quite volatile in recent ...

The smart money seems to be calling a bottom for the healthcare sector. That could mean it’s time for investors to start taking another look at the industry’s more beleaguered stocks. Since the start ...

--Pfizer's Chief Executive Albert Bourla plans to meet Starboard Value next week with at least one other director after the activist investor acquired a $1 billion stake in the healthcare company, the ...

(Reuters) - Pfizer CEO Albert Bourla plans to meet activist investor Starboard Value, the Financial Times reported on Tuesday ...

In another blow to its $525 million buyout of ReViral, Pfizer has ended development of sisunatovir, an oral inhibitor ...

The drugmaker has cut costs already and has no coming product approvals or research that could offer a quick lift.

Starboard has a roughly $1 billion stake in the drugmaker and approached former Pfizer CEO Ian Read and ex-CFO Frank D'Amelio ...

Pfizer shares have gained ground since a report over the weekend said that activist investor Starboard Value has taken a roughly $1 billion stake in the drug maker and is pushing for changes. Monitor ...

U.S. sales of RSV vaccines from GSK and Pfizer are down significantly after regulators narrowed the targeted age group and ...

Citing people familiar with the matter, The Journal reported that Starboard approached former Pfizer CEO Ian Read and CFO ...

Shares of Pfizer (NYSE:PFE) were up 4% early Monday in the wake of reports that activist investor Starboard Value had taken a ...

The creation of a pan-university Institute for Sustainability demonstrates the University of Surrey’s commitment to be at the forefront of transdisciplinary sustainability research. This Institute ...